Pathological Complete Response - Globe Thesis

Keyword [Pathological Complete Response] Result: 61 - 80 \| Page: 4 of 5
61.	Clinicopathological Features Of Breast Cancer With Low HER2 Expressionand Analysis Of Factors Related To The Efficacy Of Neoadjuvant Chemotherapy
62.	PCR Correlation Analysis Between ApoB And Neoadjuvant Chemotherapy In Invasive Breast Cancer
63.	Prediction Of Pathological Complete Response To Neoadjuvant Chemotherapy In Breast Cancer Based On MRI Intratumoral And Peritumoral Radiomics
64.	The Value Of DCE-MRI Combined With Immunohistochemistry In Breast Cancer To Assess Pathological Complete Response After Neoadjuvant Chemotherapy
65.	The Value Of Machine Learning Based On MRI And Biopsy Whole-slide Image To Predict PCR Of Breast Cancer After Neoadjuvant Chemotherapy
66.	Correlation Study Of Biomarker Expression With Efficacy And Prognosis Before And After Neoadjuvant Therapy In Breast Cancer
67.	Predictive Value Of Contrast-enhanced MRI For Pathological Complete Response Of Breast Cancer After Neoadjuvant Chemotherapy
68.	Analysis Of Factors Affecting Axillary PCR After Neoadjuvant Therapy For Breast Cancer And Feasibility Of Exempting Axillary Surgery
69.	Multiparametric MRI-Based Radiomics For Pretreatment Prediction Of Pathological Complete Response To Neoadjuvant Chemotherapy In Breast Cancer
70.	Analysis Of The Influencing Factors Related To HER2-Zero And HER2-Low Expression On The Efficacy Of Neoadjuvant Chemotherapy In HR-Positive Breast Cancer
71.	Exploring The Relationship Between Circulating Tumor DNA Methylation And The Efficacy Of Neoadjuvant Chemotherapy In Triple-Negative Breast Cancer Patients And Constructing A Prediction Model
72.	Evaluation Of The Efficacy Of Neoadjuvant Immunochemotherapy For Non-Small Cell Lung Cancer And Its Influencing Factors
73.	Predictive Value Of SII On Efficacy Of Neoadjuvant Chemotherapy And Prognosis In Breast Cancer
74.	Effect Of Chemotherapy Delay On PCR Rate Of Neoadjuvant Chemotherapy For Breast Cancer
75.	Construction And Validation Of A Predictive Model Of Pathological Complete Response Combined With MRI And Tumor Indicators For HER2-positive Breast Cancer After Neoadjuvant Targeted Therapy
76.	Application Of PET-CT Radiomics In The Treatment Of Pathological Complete Response By Neoadjuvant Immunotherapy Combined With Chemotherapy In Patients With Esophageal Squamous Cell Carcinoma
77.	Nomogram Based On Clinical,Pathologic And Imaging Features For Predicting The Pathological Complete Response From Minimal Residual Lesions After Neoadjuvant Therapy Of Breast Cancer
78.	Clinical Molecular Characteristics Of HER2-Low Breast Cancer Patients And Its Correlation With The Efficacy Of Neoadjuvant Therapy
79.	Relationship Between Tumor Regression Grade And Long-Term Prognosis After Preoperative Neoadjuvant Therapy For Locally Advanced Rectal Cancer
80.	Efficacy Analysis Of Trastuzumab Combined With Pertuzumab In The Third-Line Treatment Of HER2-Positive Breast Cancer And The Value Of SOX11 In Predicting Its Efficacy
<<First <Prev Next> Last>> Jump to